Copyright
©The Author(s) 2015.
World J Gastrointest Pathophysiol. Aug 15, 2015; 6(3): 43-50
Published online Aug 15, 2015. doi: 10.4291/wjgp.v6.i3.43
Published online Aug 15, 2015. doi: 10.4291/wjgp.v6.i3.43
Species | Type of disease | Surface phenotype | Function of MDSC | Mechanism | Ref. |
Human | Chronic HCV infection | CD11b+ HLA-DRlo CD33+ CD14+ | Inhibition of T cell proliferation and IFNγ production | Arginase1 | [6] |
Human | HCV-infected hepatocytes | CD11b+/lo HLA-DRlo/- CD33+ CD14+ | Inhibition of T cell cytokine production | ROS Cell-cell-contact | [7] |
Human | HCC | CD11b+ HLA-DR- CD33+ CD14- | Long-lasting inhibition of effector T cells | [22-30] | |
Human | HCC | HLA-DRlo/- CD14+ | Inhibition of natural killer cells | Cell-cell-contact NKp30 | [33] |
Human | HCC | HLA-DRlo/- CD14+ | Induction of Treg and inhibition of effector T cells | Arginase | [29] |
Mouse | CCl4-mediated fibrosis | CD11b+Ly6G-Ly6ChiF4/80+ | Amelioration of fibrosis through inhibition of HSC | IL-10 production | [13] |
CD11b+Ly6G+Ly6CloF4/80- | |||||
Mouse | Th1-mediated inflammation | CD11b+Ly6G-Ly6Chi | Inhibition of T cell proliferation (CD4+ and CD8+) | iNOS cell-cell-contact | [48] |
CD11b+Ly6G+Ly6Clo | |||||
Mouse | Sepsis | CD11b+Gr1+ | Inhibition of IL-12 and induction of IL-10 release by macrophages | Cell-cell-contact | [2] |
Mouse | Immune-mediated hepatitis | CD11b+Ly6GloLy6Chi | Suppression of CD4+ T cell proliferation | iNOS | [46,47] |
CD11b+Ly6G+Ly6Clo | |||||
Mouse | ConA-mediated hepatitis | CD11b+Ly6G-Ly6C+ | Protection against liver injury through inhibition of T cells | Arginase | [4] |
CD11b+Ly6G+Ly6C+(int) | |||||
Mouse | ConA/LPS-mediated hepatitis | CD11b+Ly6GloLy6Chi | Suppression of CD4+ T cell proliferation and cytokine production | iNOS cell-cell-contact | [3,45] |
CD11b+Ly6GhiLy6Cint | |||||
Mouse | CTL-mediated liver injury | CD11b+Gr1+ | Suppression of CTL proliferation and IFNγ production | [21] | |
Mouse | HBV (transgenics) | CD11b+Gr1+ | Suppression of HBV-specific CTL | Arginase iNOS | [5] |
Mouse | HCC/primary liver tumors | CD11b+Gr1+ | Suppression of anti-tumor CTL | [35,36,38] | |
Mouse | Gastrointestinal cancer with liver metastasis | CD11b+Gr1+/int | Inhibition of T cell proliferation and tumor cell lysis | [40] |
- Citation: Hammerich L, Tacke F. Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis. World J Gastrointest Pathophysiol 2015; 6(3): 43-50
- URL: https://www.wjgnet.com/2150-5330/full/v6/i3/43.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v6.i3.43